Highlights

  • Iondrive received an AUD 1,026,151 Research and Development tax incentive refund for FY26.
  • The company intends to direct the funds towards technical qualification, customer engagement and engineering.
  • Its IONSolv process is being tested on commercial magnet feedstock for rare earth recovery.
  • A larger campaign involving approximately five tonnes of magnets is targeting mixed rare earth oxide production.
  • The proposed Oklahoma processing module remains subject to funding, site decisions and other approvals.

Iondrive Limited develops selective metal-recovery technology using deep eutectic solvent chemistry, with applications spanning rare earths and other recyclable materials. Iondrive Limited (ASX:ION) announced on 3 November 2026 that it had received an AUD 1,026,151 research and development tax incentive refund relating to the financial year ended 30 June 2026. The payment supports ongoing technical and commercial preparation for recovering rare earth elements from end-of-life permanent magnets, in the United States.

FY26 Tax Refund Adds to Development Funding

The refund had previously been identified as a receivable in the September 2026 quarterly report. Iondrive Limited (ASX:ION) said the proceeds would support technical qualification, customer engagement and engineering activities associated with its IONSolv platform. The payment reimburses eligible research and development expenditure already incurred; it is not Revenue from commercial rare earth production or evidence that a processing plant has been commissioned.

At 30 September 2026, the company reported AUD 5.1 million in cash and a net operating cash outflow of AUD 2.2 million for the quarter. Its quarterly cash-flow report estimated funding for approximately 2.3 quarters at the reported expenditure rate. Option exercises contributed AUD 355,000 during the period, while no Equity raising was completed in that quarter. The refund therefore provides additional liquidity, although the future cost of development remains important.

IONSolv Trials Examine Commercial Magnet Feedstock

IONSolv uses deep eutectic solvent chemistry to extract selected metals from feedstocks. In its October quarterly update, Iondrive Limited (ASX:ION) reported independent laboratory tests on commercial United States magnet material. Single-pass leach recovery was approximately 96.5% for neodymium, 96.5%–97.3% for praseodymium and 93.5%–93.6% for dysprosium. These figures describe the leaching stage only, rather than recovery through all subsequent processing stages.

A larger campaign involving approximately five tonnes of magnets was underway in North America, with an indicative target of roughly 1.4 tonnes of mixed rare earth oxides at approximately 95% overall recovery. Completion was anticipated during the December 2026 quarter. That recovery target remains to be demonstrated by the campaign and assessed product results. Repeatable performance on commercial feedstock remains necessary before production.

Oklahoma Module Remains a Proposed Development

Iondrive Limited (ASX:ION) is assessing a site in Latimer County, Oklahoma, for a potential first commercial processing module. A September 2026 economic evaluation considered a module processing about 2,402 tonnes annually, with estimated development Capital of USD 11.9 million and a post-tax net present value of USD 243 million using a 10% real discount rate. These are study estimates, not realised returns or a final Investment decision.

The company has outlined possible government-backed financing and support, including a non-binding indication of potential Oklahoma assistance of up to approximately USD 5.2 million. It also reported five government funding applications totalling about USD 62.6 million, none of which had been awarded at the reporting date. Iondrive Limited (ASX:ION) had not finalised site tenure, secured a definitive offtake agreement or fully funded the module.

Key Insights

The FY26 refund strengthens Iondrive Limited (ASX:ION) while the company progresses magnet-processing validation and planning for a United States facility. Near-term milestones include completing the five-tonne trial, assessing mixed oxide output, advancing engineering and permitting, and exploring funding and customer arrangements. Laboratory recovery figures and economic study assumptions provide development context, but neither confirms commercial operating performance. Capital availability and execution of the proposed Oklahoma project remain central uncertainties.